111 related articles for article (PubMed ID: 20887138)
1. Cordotomy for patients with thoracic malignant astrocytoma.
Nakamura M; Tsuji O; Fujiyoshi K; Watanabe K; Tsuji T; Ishii K; Matsumoto M; Toyama Y; Chiba K
J Neurosurg Spine; 2010 Oct; 13(4):418-23. PubMed ID: 20887138
[TBL] [Abstract][Full Text] [Related]
2. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.
Kondziolka D; Flickinger JC; Bissonette DJ; Bozik M; Lunsford LD
Neurosurgery; 1997 Oct; 41(4):776-83; discussion 783-5. PubMed ID: 9316038
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
[TBL] [Abstract][Full Text] [Related]
6. Radical surgery and reoperation in supratentorial malignant glial tumors.
Daneyemez M; Gezen F; Canakçi Z; Kahraman S
Minim Invasive Neurosurg; 1998 Dec; 41(4):209-13. PubMed ID: 9932265
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
[TBL] [Abstract][Full Text] [Related]
8. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effects of microsurgery in spinal cord anaplastic astrocytoma].
Zhang L; Jia WQ; Kong DS; Zhang ZF; Yang J
Zhonghua Wai Ke Za Zhi; 2017 Jun; 55(6):441-445. PubMed ID: 28592077
[No Abstract] [Full Text] [Related]
10. Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
Krishnasamy S; Vokes EE; Dohrmann GJ; Mick R; Garcia JC; Kolker JD; Wollmann RL; Hekmatpanah J; Weichselbaum RR
Cancer Invest; 1995; 13(5):453-9. PubMed ID: 7552809
[TBL] [Abstract][Full Text] [Related]
11. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article.
Chaichana KL; Parker SL; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2009 Aug; 111(2):282-92. PubMed ID: 19344222
[TBL] [Abstract][Full Text] [Related]
12. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
14. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
15. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection.
Ewelt C; Stummer W; Klink B; Felsberg J; Steiger HJ; Sabel M
Clin Neurol Neurosurg; 2010 May; 112(4):357-61. PubMed ID: 20061079
[TBL] [Abstract][Full Text] [Related]
16. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
17. Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
Lai DM; Lin SM; Tu YK; Kao MC; Hung CC
J Formos Med Assoc; 1993 Mar; 92(3):220-6. PubMed ID: 8102273
[TBL] [Abstract][Full Text] [Related]
18. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery].
Wang YY; Bao XF; Li SY; Wu CY
Ai Zheng; 2002 Oct; 21(10):1149-53. PubMed ID: 12508664
[TBL] [Abstract][Full Text] [Related]
20. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
